Table II.

Values of laboratory investigations of inflammatory markers and fibrinolytic parameters at inclusion in the study in patients with superficial vein thrombosis treated with dalteparin 10 000 IU (group A) and dalteparin 5000 IU (group B) (values are given as mean ± SD)

Parameter	Group A (n = 35)	Group B (n = 33)	P-value
Fibrinogen [g/l]	4.2 ±1.1	3.8 ±1.2	0.141
D-dimer [ng/ml]	956 ±1019	863 ±1215	0.733
HsCRP [mg/l]	13.2 ±10.2	14.1 ±13.7	0.745
IL-6 [ng/l]	3.7 ±3.1	3.9 ±3.2	0.755
IL-8 [ng/l]	19.3 ±13.8	26.2 ±22.0	0.125
IL-10 [ng/l]	0.7 ±0.6	0.5 ±0.5	0.132
TNF-α [ng/l]	2.6 ±6.4	2.1 ±1.9	0.680
t-PA [IU/ml]	0.8 ±0.3	0.8 ±0.3	0.899
PAI-1 [IU/ml]	6.3 ±5.4	4.7 ±4.6	0.182

SD – standard deviation, hsCRP – high-sensitivity C-reactive protein, IL-6 – interleukin 6, IL-8 – interleukin 8, IL-10 – interleukin 10, TNF-α – tumor necrosis factor α, t-PA – tissue plasminogen activator, PAI-1 – plasminogen activator inhibitor-1.